Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young menMarket Watch • 12/01/25
Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/19/25
Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View RaisedZacks Investment Research • 11/07/25
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone PaymentPRNewsWire • 11/04/25
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate StrategyPRNewsWire • 10/22/25
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion PotentialBenzinga • 10/14/25
Shah Capital pushes for Novavax's sale on persistent underperformance, marketing misstepsReuters • 10/14/25
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone PaymentPRNewsWire • 10/07/25
Novavax (NVAX) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 09/23/25
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its DebutInvestors Business Daily • 09/18/25
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child DeathsZacks Investment Research • 09/15/25
Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/04/25